Share This Page
Drug Price Trends for 24HR ALLERGY-CONGST
✉ Email this page to a colleague

Average Pharmacy Cost for 24HR ALLERGY-CONGST
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
24HR ALLERGY-CONGST 180-240 MG | 70000-0607-01 | 0.86690 | EACH | 2025-01-22 |
24HR ALLERGY-CONGST 180-240 MG | 70000-0607-01 | 0.88559 | EACH | 2024-12-18 |
24HR ALLERGY-CONGST 180-240 MG | 70000-0607-01 | 0.86690 | EACH | 2024-11-20 |
24HR ALLERGY-CONGST 180-240 MG | 70000-0607-01 | 0.90428 | EACH | 2024-10-23 |
24HR ALLERGY-CONGST 180-240 MG | 70000-0607-01 | 0.90428 | EACH | 2024-09-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for 24HR Allergy Relief Drugs
Introduction to 24HR Allergy Relief Drugs
Allergy relief drugs, particularly those offering 24-hour relief, have become a staple in the treatment of various allergic conditions. Products like Claritin and Nasacort are widely recognized for their effectiveness in managing symptoms such as sneezing, runny nose, itchy eyes, and nasal congestion. Here’s a comprehensive analysis of the market and price projections for these drugs.
Market Size and Growth
The global allergy treatment market is experiencing significant growth driven by increasing cases of allergic conditions. According to Transparency Market Research, the allergy treatment market is projected to surpass $34.9 billion by 2034, growing at a CAGR of 5.8%[1].
For the specific segment of allergic rhinitis drugs, the market size is expected to grow from $14.99 billion in 2023 to $15.67 billion in 2024, with a CAGR of 4.5%. By 2028, this market is forecasted to reach $18.78 billion at a CAGR of 4.6%[4].
Key Drivers of Market Growth
Several factors are driving the growth of the allergy treatment market:
Increasing Prevalence of Allergic Conditions
The rising number of individuals suffering from allergic conditions, partly due to changing lifestyles, poor air quality, and increasing pollution, is a primary driver. These environmental factors contribute to the growing demand for effective allergy treatments[1].
Technological Advancements
Advancements in treatment methods, including the development of new antihistamines and technological advances in allergy diagnostics, are enhancing patient comfort and driving market growth. Improved allergy management techniques are expected to continue enhancing patient outcomes in the forecasted period[1][4].
Distribution Channels
Hospital pharmacies are the largest distribution channels for allergy medications, providing medicines to patients on a large scale. Retail pharmacies and online channels also play significant roles in the distribution of these drugs[1][4].
Product Overview: Claritin and Nasacort
Claritin Liquid 24-Hour
Claritin offers all-day, non-drowsy relief from pollen, dust mites, pet dander, and mold. It provides relief from sneezing, runny nose, itchy/watery eyes, and itchy nose or throat. The active ingredient is loratadine, an antihistamine[2].
Nasacort Allergy 24HR
Nasacort is a nasal spray that provides 24-hour, non-drowsy relief from nasal allergy congestion, sneezing, and runny nose. It contains a clinically proven anti-inflammatory medicine that works at the source of the allergy symptoms[5].
Price Projections and Market Trends
Current Market Pricing
The pricing of 24HR allergy relief drugs can vary based on the product, brand, and distribution channel. Generally, these products are available over-the-counter (OTC) and are priced competitively. For example, Claritin Liquid 24-Hour and Nasacort Allergy 24HR are typically priced in the range of $10 to $30 per unit, depending on the size and retailer.
Future Pricing Trends
Given the steady growth in the allergy treatment market, prices are likely to remain competitive. However, several factors could influence future pricing:
- Technological Advancements: New technologies and more effective treatments may lead to premium pricing for advanced products.
- Market Competition: Increased competition among brands could lead to price stabilization or even reductions.
- Regulatory Changes: Changes in regulatory policies or reimbursement rates could impact pricing strategies.
Distribution and Sales Channels
The distribution of 24HR allergy relief drugs is robust, with multiple channels contributing to their availability:
Hospital Pharmacies
Hospital pharmacies remain the largest distribution channel, providing medications to patients on a large scale[1].
Retail Pharmacies
Retail pharmacies, both physical and online, play a crucial role in making these products accessible to a wide audience[4].
Online Channels
Online pharmacies and e-commerce platforms are increasingly popular, offering convenience and often competitive pricing[4].
Consumer Behavior and Preferences
Consumer behavior is shifting towards more convenient and effective treatments. Here are some key preferences:
Non-Drowsy Relief
Consumers prefer non-drowsy allergy relief products to maintain their daily activities without the side effects of drowsiness[2][5].
Ease of Use
Products that are easy to use, such as nasal sprays and liquid formulations, are gaining popularity due to their convenience[2][5].
Prescription-Strength Relief
Consumers are seeking prescription-strength relief without the need for a prescription, driving the demand for OTC products like Nasacort[5].
Key Takeaways
- The global allergy treatment market is projected to grow significantly, driven by increasing allergic conditions and technological advancements.
- 24HR allergy relief drugs like Claritin and Nasacort are popular due to their non-drowsy and effective relief.
- Hospital pharmacies and retail channels are key distribution points.
- Consumer preferences lean towards convenient, non-drowsy, and prescription-strength relief.
FAQs
Q: What is the projected market size for the allergy treatment market by 2034? A: The allergy treatment market is projected to surpass $34.9 billion by 2034[1].
Q: What are the main drivers of the allergy treatment market growth? A: The main drivers include increasing prevalence of allergic conditions, technological advancements, and changing lifestyles[1].
Q: Which distribution channels are most significant for 24HR allergy relief drugs? A: Hospital pharmacies and retail pharmacies, including online channels, are the most significant distribution channels[1][4].
Q: What are the key consumer preferences for 24HR allergy relief products? A: Consumers prefer non-drowsy relief, ease of use, and prescription-strength relief without the need for a prescription[2][5].
Q: How is the allergic rhinitis drugs market expected to grow in the next few years? A: The allergic rhinitis drugs market is expected to grow from $14.99 billion in 2023 to $18.78 billion by 2028 at a CAGR of 4.6%[4].
Sources
- Transparency Market Research, Inc. - Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 at 5.8% CAGR - Report by Transparency Market Research, Inc.
- Claritin - Claritin® Liquid 24-Hour
- Allied Market Research - Allergy Treatment Market Size, Share | Statistics Report - 2031
- The Business Research Company - Global Allergic Rhinitis Drugs Market Report 2024
- Nasacort - Allergy 24HR | Nasacort® Nasal Allergy Relief Spray
More… ↓